Blog: EQUILLIUM, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) –

Item 7.01 Regulation FD Disclosure.

On June 10, 2021, Equillium, Inc. (the “Company”) issued a press release
announcing the Company’s presentation of data on target engagement and
modulation of CD6 on T Cells with Itolizumab at the International Society for
Advancement of Cytometry.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.   Description

99.1            Press release, dated June 10, 2021, issued by Equillium, Inc.
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)


© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s